Denali Therapeutics (NASDAQ:DNLI) Rating Increased to Hold at Wall Street Zen
Wall Street Zen upgraded shares of Denali Therapeutics (NASDAQ:DNLI – Free Report) from a sell rating to a hold rating in a report released on Saturday,Wall Street Zen reports. A number of other analysts also recently issued reports on DNLI. Morgan Stanley lifted their price objective on shares of Denali Therapeutics from $35.00 to $36.00 […]
20 Sep 02:12 · The Cerbat Gem